|
|
|
Volumn 13, Issue 9, 2010, Pages 595-597
|
|
American diabetes association-70th scientific sessions-research on novel therapeutics: Part 1
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
ASP 1941;
BIM 51077;
EXENDIN 4;
HEMOGLOBIN A1C;
INSULIN GLARGINE;
INT 131;
ITM 077;
LX 4211;
METFORMIN;
PIOGLITAZONE;
PLACEBO;
R 1583;
SITAGLIPTIN;
SKL 18287;
SULFONYLUREA;
TASPOGLUTIDE;
THIAZOLIDINONE DERIVATIVE;
UNCLASSIFIED DRUG;
NEW DRUG;
ABDOMINAL PAIN;
APPETITE;
AREA UNDER THE CURVE;
BACKACHE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONSTIPATION;
DIABETES MELLITUS;
DIARRHEA;
DIZZINESS;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG RESEARCH;
DRUG STABILITY;
DRUG WITHDRAWAL;
DYSPEPSIA;
EDEMA;
GENITAL TRACT INFECTION;
HEADACHE;
HUMAN;
HYPOGLYCEMIA;
INJECTION SITE NODULE;
NAUSEA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
POLLAKISURIA;
PRURITUS;
RHINOPHARYNGITIS;
SIDE EFFECT;
URINARY TRACT INFECTION;
VOMITING;
ANIMAL;
DIABETES MELLITUS, TYPE 2;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
PATHOPHYSIOLOGY;
ANIMALS;
DIABETES MELLITUS, TYPE 2;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
DRUGS, INVESTIGATIONAL;
HUMANS;
HYPOGLYCEMIC AGENTS;
|
|
EID: 77956164758
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
